MediciNova (4875) Fundamentals 2026 — Revenue Analysis | SniperIQ
MediciNova (4875) is a US-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥10.7B, trading at ¥217.00 on the JPX. This SniperIQ fundamentals page covers MediciNova's valuation, profitability (net margin -1964.3%), revenue ($409,657 in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is MediciNova's market cap?
MediciNova (4875) has a market capitalization of approximately ¥10.7B, trading at ¥217.00 on the JPX. Market cap moves with the live share price.
What is MediciNova's P/E ratio?
MediciNova's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is MediciNova?
MediciNova runs a net profit margin of -1964.3%, a gross margin of 15.2%, and an operating margin of -2164.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does MediciNova generate?
MediciNova reported revenue of $409,657 for fiscal year 2025, with net income of -
Does MediciNova pay a dividend?
MediciNova does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is MediciNova financially healthy?
MediciNova carries a debt-to-equity ratio of 0.00x and a current ratio of 9.09x, with a market beta of 0.62. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is MediciNova a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MediciNova (4875) the key facts are: market cap ¥10.7B, revenue $409,657, 52-week range 174-314. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track MediciNova's full fundamentals live
Get MediciNova's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.